Concepedia

Mary Ann Anderson

MA

108

Publications

9K

Citations

41

H-Index

1979

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

Walter and Eliza Hall Institute of Medical Research

The Royal Melbourne Hospital

The University of Melbourne

University of Illinois Chicago

Mary Ann Anderson is an author at Peter MacCallum Cancer Centre specializing in medicine, nursing, and immunology.

ORCID

Top concepts

Publications per year

1979–2024

108

Publications

108

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

Andrew W. Roberts, Matthew S. Davids, John M. Pagel et al. · New England Journal of Medicine · 2015 · 1.8K citations · Full text

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Matthew S. Davids, Andrew W. Roberts, John F. Seymour et al. · Journal of Clinical Oncology · 2017 · 737 citations · Full text

, , +17

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Constantine S. Tam, Mary Ann Anderson, Christiane Pott et al. · New England Journal of Medicine · 2018 · 417 citations

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Piers Blombery, Mary Ann Anderson, Jianan Gong et al. · Cancer Discovery · 2018 · 412 citations

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism

Mary Ann Anderson, Jing Deng, John F. Seymour et al. · Blood · 2016 · 323 citations · Full text

Rows per page

1–5 of 108